---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Rule 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

June 11, 2020

CRH MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

(604) 633-1440

(Registrant’s telephone number, including area code)

Not Applicable

(Former name of former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☑

---

The following information is filed pursuant to Item 5.07, “Submission of Matters to a Vote of Security Holders.”

On June 11, 2020, CRH Medical Corporation (the "Company"), held its 2020 annual meeting of shareholders (the “Annual Meeting”). A total of 42,704,668 common shares of the 71,583,784 common shares outstanding were voted at the Annual Meeting, representing approximately 59.66% of the issued and outstanding common shares of the Company. Set forth below are the matters acted upon by the Company’s shareholders at the Annual Meeting, and the final voting results on each matter. Each of the proposals are described in further detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on May 6, 2020.

Proposal 1 – Election of Directors

By resolution passed by ballot, the following five nominees proposed by management were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. Votes were received as follows:

Proposal 2 –Amendments to the Share Unit Plan

By resolution passed by ballot, the amendments to the Share Unit Plan and all unallocated entitlements thereof were authorized and approved. Votes were received as follows:

Proposal 3 – Appointment and Remuneration of Auditors

By resolution passed by ballot, KPMG LLP, Chartered Accountants, was appointed auditor of the Company for the ensuing year and the directors were authorized to fix their remuneration. Votes were received as follows:

A report outlining the voting results described above is filed as Exhibit 99.1 hereto.

The following information is filed pursuant to Item 8.01, “Other Events.”

On June 11, 2020, the Company issued a press release announcing the voting results of its Annual Meeting, which was filed with the Canadian securities regulatory authorities in Canada on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. A copy of this press release is filed as Exhibit 99.2 hereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.